–
The company does not admit to charges of paying a psychiatrist to prescribe Clozapine.
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at [email protected].
Thank you.
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) does not admit that it paid an Illinois psychiatrist to prescribe its antipsychotic drug Clozapine, but it has agreed to pay the $27.6 million to settle the case. It will pay Illinois state government $15.5 million and the US federal government $12.1 million.
The case goes back to November 2012, when the US filed a civil suit against Chicago psychiatrist Dr. Michael Reinstein under the False Claims Act for defrauding Medicaid and Medicare. The case against the doctor is still pending. According to the charge sheet, beginning in 2003, Ivax LLC, a company subsequently acquired by Teva, paid Dr. Reinstein $50, 000 in a consulting contract to prescribe Clozapine, and he became the largest prescriber of the drug in the US. The scheme allegedly continued after Teva acquired Ivax in 2006. The doctor and his family also received other benefits, including trips to sports events, fishing trips, and cruises, according to the Department of Justice. He also allegedly sought a job at Teva for a relative.
Published by Globes [online], Israel business news – www.globes-online.com
